Cor Vasa 2011, 53(4-5):285-291 | DOI: 10.33678/cor.2011.064

Percutaneous closure of an atrial septal defect and transcatheter aortic valve implantation in a patient with diffuse coronary artery disease

Jiří Jäger1,*, Jozef Jakabčin1, Pavel Červinka1, Antonín Novák1, Milouš Derner2, Viktor Kočka3
1 Kardiologická klinika
2 Radiologické oddělení, Masarykova nemocnice, Ústí nad Labem
3 III. interní-kardio logická klinika, Kardio cen trum, 3. lékařská fakulta Univerzity Karlovy a Fakultní nemocnice Královské Vinohrady, Praha, Česká republika

This is the case report of use of modern interventional, fully percutaneous treatment of a clinically significant, and moderately hemodynamically significant ostium secundum atrial septal defect and (also significant) degenerative calcified aortic stenosis in a 76-year-old patient with diffuse coronary artery disease and at high risk of cardiac surgery (14.4% risk using the logistic EuroSCORE). The atrial septal defect and aortic stenosis were successfully managed using a combination of two separate percutaneous interventions, implantation of a 12 mm Occlutech Figulla ("stretched" diameter, 9-10 mm) and transcatheter aortic valve implantation (TAVI) using the CoreValve Revalving 26 mm prosthesis. The procedures were uneventful, with complete left bundle branch block (LBBB), and intermittent right bundle branch block developing postprocedurally. Considering the pre-existing degree I AV block and persisting LBBB and, subsequently, the high risk of complete bundle branch block, the patient was implanted a DDDR pacemaker. Follow-up at 4 months postprocedurally documented a good effect of interventional therapy with good valve function as demonstrated by transthoracic heart ultrasound, showing no signs of a shunt at the level of atria. The patient reported appreciable improvement of his quality of life. New methods of interventional cardiology can be used to treat safely and effectively also patients at a surgical risk not acceptable to cardiac surgeons.

Keywords: Atrial septal defect; Aortic valve stenosis; Occluder; Transcatheter aortic valve implantation

Published: April 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Jäger J, Jakabčin J, Červinka P, Novák A, Derner M, Kočka V. Percutaneous closure of an atrial septal defect and transcatheter aortic valve implantation in a patient with diffuse coronary artery disease. Cor Vasa. 2011;53(4-5):285-291. doi: 10.33678/cor.2011.064.
Download citation

References

  1. Karmazín V, Želízko M, Janek B, Marek T. Katetrizační uzávěr defektu septa síní typu secundum pomocí Amplatzova septálního okluderu. Interv Akut Kardiol 2003;2:57-60.
  2. Popelová J, Benešová M, Brtko M, et al. Doporučené postupy pro diagnostiku a léčbu srdečních chlopenních vad v dospělosti. Cor Vasa 2007; 49(suppl. 11):6-46.
  3. Podmínky pro katetrizační implantaci aortální chlopně v České republice. Společný dokument pracovní skupiny České kardiologické společnosti a České společnosti kardiovaskulární chirurgie. Cor Vasa 2009;51:616-618. Go to original source...
  4. Vojáček J. První katetrizační implantace aortálních chlopní v České republice. Interv Akut Kardiol 2009;8:6-8.
  5. Vojáček J, Šťásek J, Bis J, et al. Katetrizační implantace aortální chlopně. Kardiol Rev 2009;11:143-147.
  6. Popelová J. Otevřené foramen ovale a paradoxní embolizace - antiagregační léčba, antikoagulační léčba, nebo uzávěr? Remedia 2003;13: 148-151.
  7. Branny M, Januška J, Černý J. Perkutánní katetrová implantace aortální chlopně. Cor Vasa 2009;51(suppl. 1):65-68. Go to original source...
  8. EuroSCORE. European System for Cardiac Operative Risk Evaluation. EuroSCORE Interactive Calculator. http://www.euroscore.org/calc.html
  9. Society of Thoracic Surgeons mortality score. STS Risk Calculator http://www.sts.org/sections/stsnationaldatabase/riskcalculator/
  10. Veselka J, et al. Získané chlopenní vady srdce. Praha: Medcor Europe Publishing, 2000.




Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.